Yes. It's the predictability. From our members' perspective, especially the larger companies, they really need to know what steps are going to be followed and how their innovation is going to be handled in the regulatory process. That will also give them some parameters around timelines, because the timing is really critical. If they know it's going to be 12 months for a review to get approval, they can build their business case around that. If it's going into a black box of uncertainty, that's the worst enemy for innovation. It's just very difficult to convince head offices to—